Ozempic and Pancreatitis Lawsuits: Evaluating the Link
Ozempic (semaglutide), a widely used medication for managing type 2 diabetes and weight loss, has been associated with reports of pancreatitis—a potentially serious condition involving inflammation of the pancreas. As concerns about these risks grow, some patients who have experienced pancreatitis after using Ozempic are pursuing legal action against the drug’s manufacturer, Novo Nordisk. This article explores the relationship between Ozempic and pancreatitis, highlights relevant studies, and provides insights into the ongoing legal actions. What… read more